NCB Ventures

NCB Ventures operates as the venture-oriented activity associated with NCB, a long-standing Irish wealth and corporate finance institution headquartered in Dublin. The platform provides institutional capital to Irish life sciences companies and other technology businesses, drawing on the broader NCB franchise’s relationships across Irish corporate, institutional, and high-net-worth investors. Within healthcare, the focus is on biotech and medical devices and medtech, with attention to companies whose technical and commercial profiles align with institutional capital expectations and the disciplines familiar to a wealth management and corporate finance heritage. The team gravitates toward management teams with credible scientific or operational track records and clear commercial pathways. NCB Ventures typically engages at Series A and Series B, with check sizes generally in the 1M to 5M range. The platform is comfortable participating alongside other institutional venture investors and bringing additional Irish and international syndicate participation through the broader NCB network. The capital structure supports follow-on participation in subsequent rounds where appropriate, with diligence rooted in institutional rigor. Geographic activity is concentrated in Ireland, with selective UK and European exposure where Irish-rooted companies have international growth strategies. Founders engaging NCB Ventures should expect institutional-grade diligence with attention to financial profile, governance maturity, and capital strategy, paired with post-investment engagement oriented around board-level guidance, capital introductions, and long-term capital partnership. The firm tends to favor experienced founder-operators and management teams comfortable with institutional reporting and governance norms. Limited public information is available regarding the current investing team and complete portfolio detail.